Leucine rich repeat kinase 2 inhibitors (Parkinson's disease)

SY-006

WI-211094

Leucine rich repeat kinase 2 inhibitors (University of Groningen)

LRRK2 Kinase Inhibitors (Oncodesign/Servier)

dual LRRK-2/JNK inhibitors (Scripps Research Institute)

leucine-rich repeat kinase 2 inhibitor (autoimmune disease/inflammatory disorder)

Leucine(Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %)

C₆H₁₃NO₂

D-Leucine

C₆H₁₃NO₂

Leucine enkephalin